PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25278499-0	2014	Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.	Atorvastatin	0-12	nuclear receptor subfamily 1, group H, member 4	Mus musculus	70-73	
28533986-8	2017	Atorvastatin increased the expression of Cyp7a1 in the liver, along with FXR and SHP.	Atorvastatin	0-12	nuclear receptor subfamily 1, group H, member 4	Mus musculus	73-76	
25278499-9	2014	Noticeably, atorvastatin suppressed the expression of BA nuclear receptor farnesoid X receptor (FXR) target genes, namely small heterodimer partner (liver) and fibroblast growth factor 15 (ileum).	Atorvastatin	12-24	nuclear receptor subfamily 1, group H, member 4	Mus musculus	96-99	
25278499-12	2014	The Cyp7a1 induction by atorvastatin appears to be due to suppressed FXR signaling in both the liver and intestine.	Atorvastatin	24-36	nuclear receptor subfamily 1, group H, member 4	Mus musculus	69-72	
33686046-5	2021	Results: Atorvastatin increased expression of PPARgamma, PGC-1alpha, HNF-4alpha, FXR, and CYP7A1 in Hep3B cells.	Atorvastatin	9-21	nuclear receptor subfamily 1, group H, member 4	Mus musculus	81-84	
34862975-0	2022	Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.	Atorvastatin	0-12	nuclear receptor subfamily 1, group H, member 4	Mus musculus	112-115